> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Spectrum Labs Recall 3 Epinephrine Lots
- URL: https://www.fdaweb.com/spectrum-labs-recall-3-epinephrine-lots/
- Published: 2023-01-10T12:00:00.000Z
- Updated: 2026-09-14T18:11:20.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153502

Spectrum Laboratory Products has recalled three lots of epinephrine (L-adrenaline) USP, a bulk active pharmaceutical ingredient used to manufacture or compound prescription products. The recall is based on customer complaints about product discoloration.

“The use of a finished dose product manufactured or compounded with this recalled product could result in less-effective product, and incomplete treatment of life-threatening conditions including, low blood pressure, heart failure, anaphylaxis, irregular heartbeat, and heart attack,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/spectrum-laboratory-products-inc-issues-voluntary-worldwide-recall-epinephrine-l-adrenaline-usp-bulk?utm%5Fmedium=email&utm%5Fsource=govdelivery) says. “Treatment with a less-effective product, essentially underdosing epinephrine, could result in death.”